The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma.


Erdem S. , Yegen G. , Telci D., Yildiz I., Tefik T. , Issever H. , ...Daha Fazla

World journal of urology, cilt.33, sa.10, ss.1553-60, 2015 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Konu: 10
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1007/s00345-014-1462-7
  • Dergi Adı: World journal of urology
  • Sayfa Sayıları: ss.1553-60

Özet

The aim of this study was to investigate the role of transglutaminase 2(TG2) in renal cell carcinoma (RCC) by comparing the immunohistochemistry staining of primary and metastatic tumor tissues.